Publications
Witt E, Ashworth A. Biomedicine. D-Day for BRCA2. Science (New York, N.Y.). 2002. PMID: 12065747
Harris KA, Harney E, Small EJ. Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer. Clinical prostate cancer. 2002. PMID: 15046711
Small EJ, Roach M. Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response. Seminars in oncology. 2002. PMID: 12063679
Castelli JC, Deeks SG, Shiboski S, Levy JA. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood. 2002. PMID: 12010831
Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (London, England). 2002. PMID: 12004270
Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12011123
Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273
Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991
Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991
Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141
Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. The Journal of urology. 2002. PMID: 11956415
Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141
Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, Johnson RL, Cox AD, Philips MR. Ras signalling on the endoplasmic reticulum and the Golgi. Nature cell biology. 2002. PMID: 11988737
Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010
Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116
Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010
Park JW. Liposome-based drug delivery in breast cancer treatment. Breast cancer research : BCR. 2002. PMID: 12052251
Huang F, Stremlau M. Training to think globally. Nature. 2002. PMID: 11948324
Park JW, Hong K, Kirpotin DB, Colbern G, Shalaby R, Baselga J, Shao Y, Nielsen UB, Marks JD, Moore D, Papahadjopoulos D, Benz CC. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002. PMID: 11948130
Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2002. PMID: 11996478